Mitsubishi Holdings patents expiration

1. Exservan patents expiration

EXSERVAN's oppositions filed in EPO
EXSERVAN Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765167 MITSUBISHI HOLDINGS Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2024

(4 months from now)

US8603514 MITSUBISHI HOLDINGS Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(6 months from now)

Drugs and Companies using RILUZOLE ingredient

Market Authorisation Date: 22 November, 2019

Treatment: NA


More Information on Dosage

EXSERVAN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic